Literature DB >> 22333584

Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements.

Giuliana P Mognol1, Patricia S de Araujo-Souza, Bruno K Robbs, Leonardo K Teixeira, Joao P B Viola.   

Abstract

A number of physiological processes in both normal and cancer cells are regulated by the proto-oncogene c-Myc. Among them, processes such as cell cycle regulation, apoptosis, angiogenesis and metastasis are also controlled by the nuclear factor of activated T cells (NFAT) family of transcription factors. It is already known that NFAT upregulates c-Myc expression by binding to an element located in the minimal c-Myc promoter. However, the importance of other NFAT sites in the context of the full promoter has not been evaluated. In this work, we demonstrate that the regulation of c-Myc by NFAT1 is more complex than previously conceived. In addition to the proximal site, NFAT1 directly binds to distal sites in the c-Myc promoter with different affinities. Promoter deletions and site-directed mutagenesis of NFAT binding sites in HEK293T cells suggest that in NFAT1-mediated transactivation, some NFAT elements are negative and dominant and others are positive and recessive. Furthermore, we demonstrate that cooperation with partner proteins, such as p300, enhances NFAT1-mediated transactivation of the c-Myc promoter. At last, the newly identified sites are also responsive to NFAT2 in HEK293T cells. However, in NIH3T3 cells, the regulation mediated by NFAT proteins is not dependent on the known NFAT sites, including the site previously described. Thus, our data suggest that the contribution of NFAT to the regulation of c-Myc expression may depend on a balance between the binding to positive and negative NFAT-responsive elements and cooperation with transcriptional cofactors, which may differ according to the context and/or cell type.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333584     DOI: 10.4161/cc.11.5.19518

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  18 in total

1.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

2.  NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

Authors:  V Perotti; P Baldassari; A Molla; C Vegetti; I Bersani; A Maurichi; M Santinami; A Anichini; R Mortarini
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

3.  Dichotomous role of the human mitochondrial Na+/Ca2+/Li+ exchanger NCLX in colorectal cancer growth and metastasis.

Authors:  Trayambak Pathak; Maxime Gueguinou; Vonn Walter; Celine Delierneux; Martin T Johnson; Xuexin Zhang; Ping Xin; Ryan E Yoast; Scott M Emrich; Gregory S Yochum; Israel Sekler; Walter A Koltun; Donald L Gill; Nadine Hempel; Mohamed Trebak
Journal:  Elife       Date:  2020-09-11       Impact factor: 8.140

Review 4.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

5.  Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses.

Authors:  Clair M Gardiner; Daniel W McVicar; David K Finlay; Jessica F Walls; Jeff J Subleski; Erika M Palmieri; Marieli Gonzalez-Cotto
Journal:  Elife       Date:  2020-08-19       Impact factor: 8.140

6.  Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.

Authors:  Junyan Lu; Ester Cannizzaro; Fabienne Meier-Abt; Sebastian Scheinost; Peter-Martin Bruch; Holly Ar Giles; Almut Lütge; Jennifer Hüllein; Lena Wagner; Brian Giacopelli; Ferran Nadeu; Julio Delgado; Elías Campo; Maurizio Mangolini; Ingo Ringshausen; Martin Böttcher; Dimitrios Mougiakakos; Andrea Jacobs; Bernd Bodenmiller; Sascha Dietrich; Christopher C Oakes; Thorsten Zenz; Wolfgang Huber
Journal:  Nat Cancer       Date:  2021-07-01

Review 7.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Authors:  G P Mognol; F R G Carneiro; B K Robbs; D V Faget; J P B Viola
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

8.  Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-10-20

9.  Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells.

Authors:  Vincent Kam Wai Wong; Molly Miao Zhang; Hua Zhou; Kelly Yin Ching Lam; Po Ling Chan; Carmen Ka Man Law; Patrick Ying Kit Yue; Liang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-12       Impact factor: 2.629

10.  Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma.

Authors:  Julio Finalet Ferreiro; Leila Rouhigharabaei; Helena Urbankova; Jo-Anne van der Krogt; Lucienne Michaux; Shashirekha Shetty; Laszlo Krenacs; Thomas Tousseyn; Pascale De Paepe; Anne Uyttebroeck; Gregor Verhoef; Tom Taghon; Peter Vandenberghe; Jan Cools; Iwona Wlodarska
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.